Violetta Cotreau - Jan 3, 2022 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
SVP, Chief Accounting Officer
Signature
/s/ Nicole R. Hadas, attorney-in-fact for Violetta Cotreau
Stock symbol
AKBA
Transactions as of
Jan 3, 2022
Transactions value $
-$13,335
Form type
4
Date filed
1/5/2022, 03:11 PM
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale -$13.3K -5.83K -14.99% $2.29 33.1K Jan 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on December 31, 2020.